Sign In
Buy CMRX
$8.54
+0 (+0%)
At Close: Jul 18, 2025
Chimerix: Dangerous Road, Thesis Intact
05:11am, Friday, 08'th Sep 2023
Chimerix meets financial expectations during Q2, 2023 earnings call. Investment thesis for Chimerix focuses on its ONC201 study expected to read out in 2026. Company has high risk of loss despite expe
Patients Treated with ONC201 Demonstrated Median Overall Survival (mOS) of 21.7 Months in the Front-Line Setting, Post Radiation, Versus 12 Months mOS Historical Control
Chimerix, Inc. (CMRX) Q2 2023 Earnings Call Transcript
01:10pm, Saturday, 05'th Aug 2023
Chimerix, Inc. (NASDAQ:CMRX ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Michelle Laspaluto - Vice President of Strategic Planning and Investor Relations Mike Andr
Chimerix (CMRX) Reports Q2 Loss, Misses Revenue Estimates
09:47am, Thursday, 03'rd Aug 2023
Chimerix (CMRX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.27 per share a year ago.
Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
07:00am, Thursday, 03'rd Aug 2023
– Phase 3 ACTION Study Ongoing with 77 Sites Activated Across 11 Countries; Reiterate First Interim Overall Survival Analysis Expected Early 2025 –
7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
02:17pm, Sunday, 30'th Jul 2023
Millionaire-maker penny stocks, as you might guess from the title does not represent a universally accessible sector. While these ideas can possibly make you rich, they can just as easily make you poo
Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
07:00am, Thursday, 27'th Jul 2023
DURHAM, N.C., July 27, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients fa
7 Small-Cap Stocks to Buy Before the Breakout
06:00am, Thursday, 27'th Jul 2023
When dealing with the best small-cap stocks to buy, investors effectively absorb higher risk for the possibility of substantive rewards. Even better, these rewards can come in quickly, enabling those
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
08:53pm, Tuesday, 11'th Jul 2023
Best biotech stocks represents a concept that, no matter what, the market cycle fundamentally delivers relevance. Now, let me back up by stating that no individual company offers a guarantee of succes
Chimerix: A High-Risk 'Lottery Ticket'
04:50pm, Tuesday, 06'th Jun 2023
Today, we put the spotlight on Chimerix, Inc. for the first time in 12 months. The company is advancing its primary oncology candidate in development, has a potentially large market, and sells for les
7 Deeply Undervalued Growth Stocks to Buy in June
08:04pm, Thursday, 01'st Jun 2023
Typically, securities may be less appreciated by the market because they stink, which means several proposals for best undervalued growth stocks for June might not make the cut. At the same time, bett
Chimerix's trial treating pediatric brain tumors has a 'relatively high' chance of success
04:29pm, Thursday, 25'th May 2023
The biotechnology firm Chimerix has a high probability of success in its ongoing clinical trial in the treatment of pediatric brain tumors, according to analysts at Baird. The firm initiated coverag
Chimerix, Inc. (CMRX) Q1 2023 Earnings Call Transcript
05:41pm, Saturday, 06'th May 2023
Chimerix, Inc. (NASDAQ:CMRX ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Michelle LaSpaluto - Vice President of Strategic Planning and Investor Relations Mike Sherman
Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023
07:00am, Thursday, 27'th Apr 2023
DURHAM, N.C., April 27, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients f
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
01:40pm, Wednesday, 05'th Apr 2023
While it might be difficult to navigate the equities sector now amid various headwinds, biotech stocks to buy may offer a surprising respite. True, the market presence of the surprise production cuts
